Unresectable Esophageal Carcinoma
4 clinical trials · Condition
◉ Watch Unresectable Esophageal Carcinoma
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers (NCT04460937) | National Cancer Institute (NCI) | 2021-04-09 |
| Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer (NCT03819088) | Emory University | 2019-04-17 |
| Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery (NCT03008278) | National Cancer Institute (NCI) | 2018-02-06 |
| Epacadostat and Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Junction or Gastric Cancer (NCT03196232) | George Albert Fisher | 2017-09-13 |
Track Unresectable Esophageal Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.